Buproban is a drug approved for smoking cessation. The prescription medicine works by blocking the reuptake of certain chemicals in the brain. Buproban may be used along with smoking cessation counseling. Also, in one previous study, Buproban was more effective at helping people to stop smoking when combined with nicotine patches. Buproban is typically taken twice a day as a tablet. A few side effects of Buproban include insomnia, dry mouth, and dizziness.
What Is Buproban?
Buproban® (bupropion SR) is a prescription medicine used to help people stop smoking. It is a generic version of Zyban®.
Buproban is part of a class of drugs known as norepinephrine and dopamine reuptake inhibitors (or NDRIs for short). NDRIs, such as Buproban, act on specific chemicals within the brain known as norepinephrine and dopamine. These are two of several chemicals used to send messages from one nerve cell to another.
As a message travels down a nerve, it causes the end of the cell to release norepinephrine (or dopamine). The norepinephrine (or dopamine) enters the gap between the first nerve cell and the one next to it. When enough norepinephrine or dopamine reaches the second nerve cell, it activates receptors on the cell, and the message continues on its way. The first cell then quickly absorbs any norepinephrine or dopamine that remains in the gap between cells. This is called "reuptake."
Buproban helps to block the reuptake of norepinephrine and dopamine so that more of each chemical remains in the space between the brain's nerve cells. This gives these substances a better chance of activating the receptors on the next nerve cell. It is thought that this action helps people to be more successful at quitting smoking.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Wellbutrin [package insert]. Research Triangle Park, NC: GlaxoSmithKline;2011 July.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed February 19, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click